# Innovative "Scoring System" in Breast Cancer Post Neoadiuvant Chemotherapy

> **NCT05213403** · — · COMPLETED · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 255 (actual)

## Conditions studied

- Early Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Evaluation with new scoring system

## Key facts

- **NCT ID:** NCT05213403
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-01
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2022-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05213403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05213403, "Innovative "Scoring System" in Breast Cancer Post Neoadiuvant Chemotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05213403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*